Lpa2 receptor agonist inhibitors of cftr

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/685 (2006.01) A61K 31/665 (2006.01)

Patent

CA 2615836

Methods and compositions for treating or preventing diarrhea are disclosed. The methods comprise administering to an individual a therapeutically effective amount of an LPA2 receptor agonist for treating or preventing diarrhea. Also disclosed is a method of inhibiting CFTR activation by administering at least one LPA2 receptor agonist in an amount effective to inhibit formation of a macromolecular complex between the LPA2 receptor, CFTR, and a Na+/H+ exchange regulatory factor-2 (NHERF-2).

L'invention concerne des procédés et compositions permettant de traiter ou de prévenir la diarrhée. Ces procédés consistent à administrer à un patient une quantité thérapeutiquement efficace d'un agoniste du récepteur LPA2 pour traiter ou prévenir la diarrhée. L'invention concerne également un procédé d'inhibition de l'activation de CFTR par l'administration d'au moins un agoniste du récepteur LPA2 en quantité efficace pour inhiber la formation d'un complexe macromoléculaire entre le récepteur LPA2, CFTR et un facteur-2 de régulation de l'échange Na+/H+ (NHERF-2).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Lpa2 receptor agonist inhibitors of cftr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lpa2 receptor agonist inhibitors of cftr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lpa2 receptor agonist inhibitors of cftr will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2048893

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.